Magnesium orotate

Clinical data
AHFS/Drugs.com	Consumer Drug Information
ATC code	A12CC09 (WHO)
Identifiers
IUPAC name magnesium 2,6-dioxo-3H-pyrimidine-4-carboxylate
CAS Number	34717-03-8 Y
PubChem CID	3036905
ChemSpider	2300801
UNII	GI96W46M5A
CompTox Dashboard (EPA)	DTXSID20905129
ECHA InfoCard	100.047.410
Chemical and physical data
Formula	C10H6MgN4O8
Molar mass	334.483 g·mol−1
3D model (JSmol)	Interactive image
SMILES [Mg+2].O=C([O-])\C1=C\C(=O)NC(=O)N1.[O-]C(=O)\C1=C\C(=O)NC(=O)N1
InChI InChI=1S/2C5H4N2O4.Mg/c2*8-3-1-2(4(9)10)6-5(11)7-3;/h2*1H,(H,9,10)(H2,6,7,8,11);/q;;+2/p-2 Key:QWLHYYKDLOVBNV-UHFFFAOYSA-L
(verify)

Magnesium orotate, the magnesium salt of orotic acid, is a mineral supplement. It can be used in treating extracellular magnesium deficiency, as well as in mitigating magnesium depletion that inhibits the binding of adenosine triphosphate via orotic acid, which provides binding sites.^[1]